Press release
Global Pediatric Drugs Market Projected to Surpass $316 Billion by 2029 with 14.9% Annual Growth
Pediatric Drugs
The growing number of preterm births is expected to propel the growth of the pediatric drugs market. Preterm births, which occur before 37 weeks of pregnancy, are influenced by factors such as increased maternal age, lifestyle choices, medical conditions, and inadequate prenatal care. Pediatric drugs are crucial in supporting the health and development of premature infants, addressing issues like respiratory problems, infections, and nutritional gaps. For instance, in 2022, the percentage of premature births in England and Wales rose to 7.9%, up from 7.5% in 2021, with over 53,000 premature births recorded. As a result, the increasing number of preterm births is driving the growth of the pediatric drugs market.
Get Your Pediatric Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report
What is the projected compound annual growth rate (CAGR) of the pediatric drugs market from 2025 to 2034, and what factors influence it?
The pediatric drugs market has grown rapidly, increasing from $157.0 billion in 2024 to $181.02 billion in 2025 at a CAGR of 15.3%. Growth has been fueled by demand from a high pediatric population, increased awareness of pediatric diseases, expansion of pediatric oncology, the rise of digital health and telemedicine, and growing collaborations in pediatric drug development.
The pediatric drugs market is projected to see substantial growth, reaching $316.0 billion by 2029, at a CAGR of 14.9%. Growth factors include a growing pediatric population, increased prevalence of pediatric mental health conditions, a rising number of children with chronic illnesses, higher vaccination rates, and increased demand for pediatric mental health medications. Emerging trends involve personalized pediatric medicine, integration of technology in drug delivery, telemedicine and digital health adoption, enhanced pediatric clinical trials, and strengthened collaboration between pediatricians and pharmacists.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp
How are the latest trends influencing the growth of the pediatric drugs market?
In the pediatric drugs market, companies are focusing on fully human monoclonal antibodies to minimize side effects and improve treatment efficacy for children. For instance, in August 2022, Johnson & Johnson received FDA approval for STELARA (ustekinumab) for treating pediatric patients aged 6 and older with active psoriatic arthritis (PsA). STELARA is the first biologic therapy targeting interleukin-12 (IL-12) and interleukin-23 (IL-23), offering a novel approach to managing this rare inflammatory condition in children.
What are the major segments of the pediatric drugs market and their role in driving growth?
The pediatric drugs market covered in this report is segmented -
1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs
2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids
2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)
3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives
4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21249
Which regions are key players in the growth of the pediatric drugs market?
North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the pediatric drugs market?
Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp
What Is Covered In The Pediatric Drugs Global Market Report?
•Market Size Forecast: Examine the pediatric drugs market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the pediatric drugs market for a structured understanding.
•Key Players Overview: Analyze major players in the pediatric drugs market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pediatric drugs market.
•Segment Contributions: Evaluate how different segments drive overall growth in the pediatric drugs market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pediatric drugs market.
•Industry Challenges: Identify potential risks and obstacles affecting the pediatric drugs market.
•Competitive Landscape: Review strategic developments in the pediatric drugs market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pediatric Drugs Market Projected to Surpass $316 Billion by 2029 with 14.9% Annual Growth here
News-ID: 3935172 • Views: …
More Releases from The Business Research Company
Global Subcutaneous Immunoglobulin (SCIG) Market Projected to Grow at 12.7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Subcutaneous Immunoglobulin (SCIG) Industry Market Size Be by 2025?
The market for subcutaneous immunoglobulin (SCIG) has seen a swift expansion in the recent past. The market size is projected to escalate from $12.72 billion in 2024 to $14.39 billion in 2025, reflecting a compound annual growth…
2025-2034 Ranibizumab Market Roadmap: Insights for Competitive Advantage
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Ranibizumab Market Size By 2025?
The market for ranibizumab has experienced steady expansion in the past few years, with projections stating it will increase from $2.66 billion in 2024 to $2.76 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.6%. The growth…
Emerging Peptide And Oligonucleotide CDMO Market Trends: Strategic Partnerships …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Peptide And Oligonucleotide CDMO Market Size Growth Forecast: What to Expect by 2025?
In recent years, the peptide and oligonucleotide cdmo market has witnessed a swift escalation in its size. From $2.16 billion in 2024, it is projected to surge up to $2.42 billion in 2025 with a compound…
Oral Solid Dosage Pharmaceutical Formulation: Critical Driver Shaping the Chroni …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Oral Solid Dosage Pharmaceutical Formulation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for oral solid dosage pharmaceutical formulations has seen robust growth in the last few years. Its size is expected to increase from $618.34 billion in 2024 to $653.26 billion in…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
